Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Columbia University is initiating a clinical trial to evaluate whether the herbal supplement Zyflamend inhibits the onset of prostate cancer in certain patients - Nutraceuticals World

What are you searching for?

Sign in

Columbia University is initiating a clinical trial to evaluate whether the herbal supplement Zyflamend inhibits the onset of prostate cancer in certain patients

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Columbia University is initiating a clinical trial to evaluate whether the herbal supplement Zyflamend inhibits the onset of prostate cancer in certain patients. New Chapter, the Brattleboro, VT-based firm that manufactures the supplement, is providing funding for the Phase I study. The trial is the first clinical examination of its kind for an herbal prostate cancer prevention treatment, according to a Columbia University press release. Zyflamend is composed of 10 herbs purported to work along the COX-2 pathway: rosemary; turmeric; holy basil; ginger; green tea; Chinese goldthread; hu zhang; oregano; barberry; and Baikal skullcap…

—The Tan Sheet, 9/27/04

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters